Presentation27 Jun 2018 09:14
The interview posted below explaining where we are now, key points: Under budget, Revenues, reduced Cash burn , collaborations, Next 18months will be interesting- it’s Monkeys next! Remember we have two Multibillion Nasdaq listed biotech,s on board one is 60-70billions the other 80+ Billions , looks like that 2.5m shareholding will be doing exceptionally well over the next couple of years.